Literature DB >> 6775956

Renal handling of urate in healthy man in hyperuricaemia and renal insufficiency: circadian fluctuation, effect of water diuresis and of uricosuric agents.

F Lang, R Greger, H Oberleithner, E Griss, K Lang, D Pastner, P Dittrich, P Deetjen.   

Abstract

To differentiate between extrarenal and renal causes of hyperuricaemia and gout, clearances of urate and creatinine were monitored for 3 1/2 days in fifty-two individuals (seven with a history of gout) with no gross impairment of renal function (creatinine clearance 52-137 ml/min). Dietary purine intake was kept constant. Monophasic circadian fluctuations of fractional urate excretion (= urate clearance over creatinine clearance) were observed with peak values in the afternoon, about 50% higher than during the night. Circadian fluctuations of urinary flow rate were almost identical. However, enhancement of urinary flow rate due to water diuresis had no effect on urate clearance. Despite wide variation of plasma urate concentrations among different individuals (+/- 30% SD), daily urate excretion varied little (+/- 4% SD) and did not correlate with plasma urate (r = 0.03). Thus extrarenal factors appear not to account for the occurrence of hyperuricaemia in these patients. In contrast, a clearcut negative correlation was apparent between plasma urate concentration and fractional urate clearance (r = 0.72), which could fully account for the variations of plasma urate concentration. To elucidate further the mechanism responsible for antiuricosuria in hyperuricaemic patients, the effects of the uricosuric agents benzbromarone and probenecid were tested. A clearcut correlation was apparent between control fractional urate excretion and uricosuric effect of both benzbromarone and probenecid (r = 0.83 and 0.88, respectively), suggesting that anti-uricosuria was due to defective secretion. In an additional series, the uricosuric effect of probenecid was tested in ten patients with renal insufficiency. In these patients the uricosuric effect was clearly blunted, indicating that urate reabsorption is reduced in renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775956     DOI: 10.1111/j.1365-2362.1980.tb00035.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

1.  Circadian Periodicity of Circulating Plasma Lipid Peroxides, Uric Acid and Ascorbic Acid in Renal Stone Formers.

Authors:  Rajeev Singh Kushwaha; R C Gupta; J P Sharma; Sumita Sharma; Raj Kumar Singh; Germaine Cornelissen
Journal:  Indian J Clin Biochem       Date:  2016-07-15

2.  The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia.

Authors:  Youssef M Roman
Journal:  Hawaii J Med Public Health       Date:  2019-02

3.  Effect of Gender, Age, Diet and Smoking Status on the Circadian Rhythm of Serum Uric Acid of Healthy Indians of Different Age Groups.

Authors:  Ranjana Singh; Pramod Kumar; Devendra Nath Mishra; Ashok Kumar Singh; Raj Kumar Singh; Abbas Ali Mahdi; Cathy Lee Gierke; Germaine Cornelissen
Journal:  Indian J Clin Biochem       Date:  2017-12-21

Review 4.  Circadian clocks of the kidney: function, mechanism, and regulation.

Authors:  Hannah M Costello; Jermaine G Johnston; Alexandria Juffre; G Ryan Crislip; Michelle L Gumz
Journal:  Physiol Rev       Date:  2022-05-16       Impact factor: 46.500

5.  Gout and uric acid nephropathy: some new aspects in diagnosis and treatment.

Authors:  W Löffler; H A Simmonds; W Gröbner
Journal:  Klin Wochenschr       Date:  1983-12-15

6.  Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Authors:  Sophie L Stocker; Kenneth M Williams; Andrew J McLachlan; Garry G Graham; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Pharmacokinetic and pharmacodynamic studies of tienilic acid in healthy volunteers.

Authors:  A L Kerremans; F W Gribnau; Y Tan; C A van Ginneken
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients.

Authors:  Diluk R W Kannangara; Sheena N Ramasamy; Praveen L Indraratna; Sophie L Stocker; Garry G Graham; Graham Jones; Ian Portek; Kenneth M Williams; Richard O Day
Journal:  Arthritis Res Ther       Date:  2012-08-17       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.